Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Early human screening of medications to treat drug addiction: novel paradigms and the relevance of pharmacogenetics.

Perkins KA, Lerman C.

Clin Pharmacol Ther. 2011 Mar;89(3):460-3. doi: 10.1038/clpt.2010.254. Epub 2011 Jan 26. No abstract available.

2.

Pharmacogenetics and stroke.

Meschia JF.

Stroke. 2009 Nov;40(11):3641-5. doi: 10.1161/STROKEAHA.109.562231. Epub 2009 Sep 17. Review.

3.

Pharmacogenetic Markers of Drug Efficacy and Toxicity.

Yip VL, Hawcutt DB, Pirmohamed M.

Clin Pharmacol Ther. 2015 Jul;98(1):61-70. doi: 10.1002/cpt.135. Epub 2015 Jun 3. Review.

PMID:
25870137
4.

The role of human drug self-administration procedures in the development of medications.

Comer SD, Ashworth JB, Foltin RW, Johanson CE, Zacny JP, Walsh SL.

Drug Alcohol Depend. 2008 Jul 1;96(1-2):1-15. doi: 10.1016/j.drugalcdep.2008.03.001. Epub 2008 Apr 24. Review.

5.

Symbiotic relationship of pharmacogenetics and drugs of abuse.

Rutter JL.

AAPS J. 2006 Mar 24;8(1):E174-84. Review.

6.

Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment.

Khokhar JY, Ferguson CS, Zhu AZ, Tyndale RF.

Annu Rev Pharmacol Toxicol. 2010;50:39-61. doi: 10.1146/annurev.pharmtox.010909.105826. Review.

PMID:
20055697
7.

[Pharmacogenetics and the treatment of addiction].

Schellekens A.

Ned Tijdschr Geneeskd. 2013;157(23):A5725. Review. Dutch.

PMID:
23739600
8.

Pharmacogenetics of addiction therapy.

Nielsen DA, Nielsen EM, Dasari T, Spellicy CJ.

Methods Mol Biol. 2014;1175:589-624. doi: 10.1007/978-1-4939-0956-8_15. Review.

PMID:
25150877
9.

Promise of new translational safety biomarkers in drug development and challenges to regulatory qualification.

Sistare FD, DeGeorge JJ.

Biomark Med. 2011 Aug;5(4):497-514. doi: 10.2217/bmm.11.52. Review.

PMID:
21861671
10.

Clinically relevant genetic variations in drug metabolizing enzymes.

Pinto N, Dolan ME.

Curr Drug Metab. 2011 Jun;12(5):487-97. Review.

11.

Breaking barriers in the genomics and pharmacogenetics of drug addiction.

Ho MK, Goldman D, Heinz A, Kaprio J, Kreek MJ, Li MD, Munafò MR, Tyndale RF.

Clin Pharmacol Ther. 2010 Dec;88(6):779-91. doi: 10.1038/clpt.2010.175. Epub 2010 Oct 27. Review.

12.

Identifying genomic and developmental causes of adverse drug reactions in children.

Becker ML, Leeder JS.

Pharmacogenomics. 2010 Nov;11(11):1591-602. doi: 10.2217/pgs.10.146. Review.

13.

The pharmacogenetics research network: from SNP discovery to clinical drug response.

Giacomini KM, Brett CM, Altman RB, Benowitz NL, Dolan ME, Flockhart DA, Johnson JA, Hayes DF, Klein T, Krauss RM, Kroetz DL, McLeod HL, Nguyen AT, Ratain MJ, Relling MV, Reus V, Roden DM, Schaefer CA, Shuldiner AR, Skaar T, Tantisira K, Tyndale RF, Wang L, Weinshilboum RM, Weiss ST, Zineh I; Pharmacogenetics Research Network.

Clin Pharmacol Ther. 2007 Mar;81(3):328-45. Review.

PMID:
17339863
14.

A generic operational strategy to qualify translational safety biomarkers.

Matheis K, Laurie D, Andriamandroso C, Arber N, Badimon L, Benain X, Bendjama K, Clavier I, Colman P, Firat H, Goepfert J, Hall S, Joos T, Kraus S, Kretschmer A, Merz M, Padro T, Planatscher H, Rossi A, Schneiderhan-Marra N, Schuppe-Koistinen I, Thomann P, Vidal JM, Molac B.

Drug Discov Today. 2011 Jul;16(13-14):600-8. doi: 10.1016/j.drudis.2011.04.011. Epub 2011 May 6. Review.

PMID:
21570476
15.

What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects?

Ozdemir V, Shear NH, Kalow W.

Drug Saf. 2001;24(2):75-85. Review.

PMID:
11235820
16.

Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.

Trent RJ, Cheong PL, Chua EW, Kennedy MA.

Pathology. 2013 Jun;45(4):357-70. doi: 10.1097/PAT.0b013e328360b66e. Review.

PMID:
23594690
17.

Pharmacogenomic importance of ABCG2.

Cusatis G, Sparreboom A.

Pharmacogenomics. 2008 Aug;9(8):1005-9. doi: 10.2217/14622416.9.8.1005. Review.

18.

Pharmacogenetics: past, present and future.

Pirmohamed M.

Drug Discov Today. 2011 Oct;16(19-20):852-61. doi: 10.1016/j.drudis.2011.08.006. Epub 2011 Aug 22. Review.

PMID:
21884816
19.

Pharmacogenetics of drug hypersensitivity.

Phillips EJ, Mallal SA.

Pharmacogenomics. 2010 Jul;11(7):973-87. doi: 10.2217/pgs.10.77. Review.

20.

Development of pharmacotherapies for drug addiction: a Rosetta stone approach.

Koob GF, Kenneth Lloyd G, Mason BJ.

Nat Rev Drug Discov. 2009 Jun;8(6):500-15. doi: 10.1038/nrd2828. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk